Dr. Shrikanth U Pankanti

Dr Shrikanth U Pankanti is a Clinical Pathologist and Laboratory Medicine specialist with 39 years of clinical experience in pathology, histopathology, cytopathology, and laboratory diagnostics.

Dr Shrikanth is currently associated with CARE Hospitals, Banjara Hills, Hyderabad, where he serves as Clinical Director and Head of the Pathology Department.

Dr Shrikanth Pankanti specialises in clinical pathology and laboratory medicine contributing to accurate disease diagnosis and effective patient management across a wide range of clinical specialities.

Area of Expertise

Histopathology and Tissue Diagnosis

He provides expert histopathological evaluation of tissue specimens for the diagnosis of benign and malignant conditions, offering precise and detailed reporting to guide clinical decision-making and treatment planning.

Cytopathology and Diagnostic Cytology

Dr Shrikanth U Pankanti performs cytopathological assessment of cellular specimens including fine needle aspiration cytology and exfoliative cytology, enabling accurate early diagnosis of a wide range of inflammatory, infective, and neoplastic conditions.

Laboratory Medicine and Clinical Pathology

He oversees comprehensive laboratory medicine and clinical pathology services, ensuring accurate diagnostic reporting, quality control, and laboratory management for a broad spectrum of clinical and investigative requirements across the hospital.

Hospital Associations

• Currently associated as Clinical Director and Head of Pathology at CARE Hospitals, Banjara Hills, Hyderabad

Education and Qualifications

• MBBS – Marathwada University, 1987
• MD Pathology – Marathwada University, 1991
• Telangana State Medical Council – Registration No. 5194, 2018

Book an Appointment with Dr Shrikanth U Pankanti, Clinical Pathologist in Hyderabad

To consult Dr Shrikanth U Pankanti for histopathology, cytopathology, or laboratory medicine services, visit CARE Hospitals, Banjara Hills, Hyderabad. Check his contact details and availability through HexaHealth today.